Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA442473
Max Phase: Preclinical
Molecular Formula: C53H85N7O11
Molecular Weight: 996.30
Molecule Type: Small molecule
Associated Items:
ID: ALA442473
Max Phase: Preclinical
Molecular Formula: C53H85N7O11
Molecular Weight: 996.30
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCCCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O
Standard InChI: InChI=1S/C53H85N7O11/c1-6-7-8-9-10-11-12-13-14-15-16-17-21-27-44(64)58-46(36(4)61)52(69)59-45(35(2)3)50(67)60-47(37(5)62)51(68)56-42(33-39-28-30-40(63)31-29-39)49(66)55-41(26-22-23-32-54)48(65)57-43(53(70)71)34-38-24-19-18-20-25-38/h18-20,24-25,28-31,35-37,41-43,45-47,61-63H,6-17,21-23,26-27,32-34,54H2,1-5H3,(H,55,66)(H,56,68)(H,57,65)(H,58,64)(H,59,69)(H,60,67)(H,70,71)/t36-,37-,41+,42+,43+,45+,46+,47+/m1/s1
Standard InChI Key: ZNCWQWCMFDOVGB-SNPCEKNGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 996.30 | Molecular Weight (Monoisotopic): 995.6307 | AlogP: 4.20 | #Rotatable Bonds: 37 |
Polar Surface Area: 298.61 | Molecular Species: ZWITTERION | HBA: 11 | HBD: 11 |
#RO5 Violations: 3 | HBA (Lipinski): 18 | HBD (Lipinski): 12 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.70 | CX Basic pKa: 17.64 | CX LogP: 3.28 | CX LogD: 3.27 |
Aromatic Rings: 2 | Heavy Atoms: 71 | QED Weighted: 0.04 | Np Likeness Score: 0.22 |
1. Basse N, Papapostolou D, Pagano M, Reboud-Ravaux M, Bernard E, Felten AS, Vanderesse R.. (2006) Development of lipopeptides for inhibiting 20S proteasomes., 16 (12): [PMID:16630721] [10.1016/j.bmcl.2006.03.033] |
Source(1):